Mangoceuticals Income Statement (2023-2025) | MGRX

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.10M0.14M0.25M0.24M0.21M0.16M0.13M0.11M0.11M0.17M0.08M
Cost of Revenue 0.02M0.03M0.05M0.05M0.02M0.03M0.02M0.02M0.02M0.02M0.00M
Gross Profit 0.06M0.09M0.14M0.14M0.15M0.07M0.08M0.08M0.06M0.09M0.05M
Operating items
Selling, General & Administrative 0.13M0.57M0.54M0.82M0.77M0.85M0.52M0.85M1.54M1.25M0.31M
Other Operating Expenses 2.49M1.81M1.40M1.89M1.74M1.39M1.32M0.90M3.37M4.11M7.28M
Operating Expenses 2.62M2.38M1.94M2.71M2.52M2.24M1.84M1.76M4.92M5.36M7.59M
Operating Income -2.56M-2.29M-1.80M-2.57M-2.37M-2.17M-1.76M-1.68M-4.85M-5.27M-7.54M
EBIT -2.56M-2.29M-1.80M-2.57M-2.37M-2.17M-1.76M-1.68M-4.85M-5.27M-7.54M
Non-operating items
Other Non Operating Income -0.13M
Non Operating Income -0.00M0.01M-0.22M-0.24M-0.27M0.01M-0.15M-0.08M
Net income details
EBT -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Profit After Tax -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Income from Non-Controlling Interests -1.80M-36.00-340.00-461.00-244.00-98.00-2.00-558.00
Income from Continuing Operations -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Consolidated Net Income -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Income towards Parent Company -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Preferred Dividend Payments 0.29M0.29M
Net Income towards Common Stockholders -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.29M-1.95M-4.84M-5.42M-7.91M
Additional items
EPS (Basic) -0.23-0.14-1.70-1.90-1.50-1.37-1.14-0.98-1.29-0.57-0.69
EPS (Weighted Average and Diluted) -0.23-0.14-1.70-1.90-1.50-1.37-1.14-0.98-1.29-0.57-0.69
Shares Outstanding (Weighted Average) 11.26M15.77M1.06M1.07M1.57M1.74M2.01M1.98M4.59M7.28M11.52M
Shares Outstanding (Diluted Average) 11.26M15.77M1.06M1.07M1.57M1.74M2.01M1.98M4.59M9.98M11.52M
EBITDA -2.56M-2.29M-1.80M-2.57M-2.37M-2.17M-1.76M-1.68M-4.85M-5.27M-7.54M
Interest Expenses -0.01M0.02M0.08M